- Home
- HOND vs JSPR Comparison
HOND vs JSPR Comparison
Compare HOND & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOND
- JSPR
- Stock Information
- Founded
- HOND 2024
- JSPR 2018
- Country
- HOND United States
- JSPR United States
- Employees
- HOND N/A
- JSPR N/A
- Industry
- HOND
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOND
- JSPR Health Care
- Exchange
- HOND NYSE
- JSPR Nasdaq
- Market Cap
- HOND 334.9M
- JSPR 85.8M
- IPO Year
- HOND 2024
- JSPR N/A
- Fundamental
- Price
- HOND $11.10
- JSPR $3.04
- Analyst Decision
- HOND
- JSPR Strong Buy
- Analyst Count
- HOND 0
- JSPR 10
- Target Price
- HOND N/A
- JSPR $50.50
- AVG Volume (30 Days)
- HOND 468.5K
- JSPR 1.0M
- Earning Date
- HOND 01-01-0001
- JSPR 08-12-2025
- Dividend Yield
- HOND N/A
- JSPR N/A
- EPS Growth
- HOND N/A
- JSPR N/A
- EPS
- HOND 0.20
- JSPR N/A
- Revenue
- HOND N/A
- JSPR N/A
- Revenue This Year
- HOND N/A
- JSPR N/A
- Revenue Next Year
- HOND N/A
- JSPR N/A
- P/E Ratio
- HOND $54.26
- JSPR N/A
- Revenue Growth
- HOND N/A
- JSPR N/A
- 52 Week Low
- HOND $9.90
- JSPR $2.27
- 52 Week High
- HOND $12.24
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- HOND N/A
- JSPR 29.92
- Support Level
- HOND N/A
- JSPR $5.35
- Resistance Level
- HOND N/A
- JSPR $7.19
- Average True Range (ATR)
- HOND 0.00
- JSPR 0.62
- MACD
- HOND 0.00
- JSPR -0.11
- Stochastic Oscillator
- HOND 0.00
- JSPR 15.74
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.